EUVIMEDEUVIMED entdecken
Open Access

Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances

Merci Ujeneza, Jessica Tardif, Erin Thompson, Adina Badea, Alexis Morales, Cole Altomare-Jarczyk, Traci C Green, Rachel Serafinski, Michelle McKenzie iD, Ju Nyeong Park

Drug and Alcohol Review · 2025-11 · 44 (7) · 1866-1874

DOI: 10.1111/dar.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Review, online erschienen am 21.09.2025. Verfasst von Merci Ujeneza und 9 weiteren Autor:innen. Beteiligte Einrichtung: COBRE on Opioids and Overdose, Rhode Island Hospital, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Fentanyl, Illicit Drugs, Xylazine, Point-of-Care Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDA NIH HHS, National Institutes of Health, National Institute of Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The illicit drug supply constantly fluctuates, with new adulterants and unexpected mixtures creating uncertainty. Point‐of‐care drug‐checking services are vital in reducing overdose risk and other harms by providing real‐time analysis, harm reduction education and links to care. This study aimed to characterise the local drug supply using Fourier transform infrared (FTIR) spectroscopy, complemented by Liquid Chromatography‐Quadrupole time‐of‐flight Mass Spectrometry (LC‐QToF‐MS) for additional context, from drug residues collected through a drug‐checking program within a Rhode Island harm reduction site.

Methods

From January to May 2023, 100 samples were analysed using FTIR and sent for additional qualitative and semi‐quantitative testing via LC‐QToF‐MS. Substances detected by both methods were summarised by prevalence, mixture composition and alignment with self‐reported drug categories.

Results

Fentanyl (53%) and cocaine (48%) were the most prevalent substances detected by FTIR, followed by xylazine (10%) and methamphetamine (8%). Cross‐category analysis revealed cocaine in 36% of opioid‐reported samples and fentanyl in 3% of self‐reported cocaine samples, underscoring the mixed nature of the supply. We found the local fentanyl supply ( n = 57) showed high variability, with 15 additional components detected by FTIR, including xylazine (19.3%). Discussion and Conclusions These findings provide a snapshot of the unpredictable and highly mixed nature of the Rhode Island drug supply defined by stimulant‐opioid overlaps, xylazine adulteration and the presence of cocaine across drug categories. By pairing real‐time FTIR with laboratory‐based analysis, we provided actionable information back to service users while also uncovering deeper patterns in local drug trends.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylIllicit DrugsXylazinePoint-of-Care SystemsSubstance Abuse DetectionDrug ContaminationRhode IslandHumansSpectroscopy, Fourier Transform Infrared

Stichwörter der Autor:innen

drug‐checkingharm reductionoverdosesubstance usexylazine

Substanzen

FentanylIllicit DrugsXylazine

Autor:innen und Institutionen

  • COBRE on Opioids and Overdose, Rhode Island Hospital, Providence, Rhode Island, USA.
  • Department of Pathology and Laboratory Medicine, Brown University Health, Providence, Rhode Island, USA.
  • Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Project Weber Renew, Pawtucket, Rhode Island, USA.
  • Heller School for Social Policy and Management, Brandeis University, Waltham, Rhode Island, USA.

ORCID-Profile: Michelle McKenzie

Förderung

  • NIGMS NIH HHS
  • NIDA NIH HHS
  • National Institutes of Health, National Institute of Drug Abuse
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Ujeneza, M., Tardif, J., Thompson, E., Badea, A., Morales, A., Altomare-Jarczyk, C., Green, T. C., Serafinski, R., McKenzie, M., & Park, J. N. (2025). Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances. Drug and Alcohol Review, 44(7), 1866-1874. https://doi.org/10.1111/dar.70037

Vancouver

Ujeneza M, Tardif J, Thompson E, Badea A, Morales A, Altomare-Jarczyk C, et al. Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances. Drug and Alcohol Review. 2025;44(7):1866-1874. doi:10.1111/dar.70037

BibTeX
@article{Ujeneza2025,
  author = {Ujeneza, Merci and Tardif, Jessica and Thompson, Erin and Badea, Adina and Morales, Alexis and Altomare-Jarczyk, Cole and Green, Traci C and Serafinski, Rachel and McKenzie, Michelle and Park, Ju Nyeong},
  title = {Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances},
  journal = {Drug and Alcohol Review},
  year = {2025},
  volume = {44},
  number = {7},
  pages = {1866--1874},
  doi = {10.1111/dar.70037}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche